• Galapagos' osteoarthritis drug flunks phase 2, dashing hopes of $250M Gilead deal

    11 days ago - By Fierce Biotech

    Galapagos' osteoarthritis drug flunks phase 2, dashing hopes of $250M Gilead deal ntaylor
    Fri, 10/16/2020 - 03:48
    Read more ...